163 related articles for article (PubMed ID: 9868032)
21. [The validity of the proteins concentrations in the ascitic liquid and serum for the differential diagnosis of the ascitis].
Valdivia R M; Llanos C A; Zapata S C; Muñoz O N
Rev Gastroenterol Peru; 2002; 22(4):279-86. PubMed ID: 12525843
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
23. CEA, AFP and CA 19-9 analysis in peritoneal fluid to differentiate causes of ascites formation.
Kaleta EJ; Tolan NV; Ness KA; O'Kane D; Algeciras-Schimnich A
Clin Biochem; 2013 Jun; 46(9):814-8. PubMed ID: 23454392
[TBL] [Abstract][Full Text] [Related]
24. Study of effusion cytology in patients with simultaneous malignancy and ascites.
Jha R; Shrestha HG; Sayami G; Pradhan SB
Kathmandu Univ Med J (KUMJ); 2006; 4(4):483-7. PubMed ID: 18603959
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malignant and nonmalignant ascites.
Nascimento I; Schaer R; Lemaire D; Freire S; Paule B; Carvalho S; Meyer R; Schaer-Barbosa H
APMIS; 2004 Sep; 112(9):585-7. PubMed ID: 15601306
[TBL] [Abstract][Full Text] [Related]
26. Value of ascitic fluid ferritin in the differential diagnosis of malignant ascites.
Kountouras J; Boura P; Tsapas G; Charisis K; Magoula I; Tsakiri I
Anticancer Res; 1993; 13(6B):2441-5. PubMed ID: 8135481
[TBL] [Abstract][Full Text] [Related]
27. The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis.
Khandwalla HE; Fasakin Y; El-Serag HB
Am J Gastroenterol; 2009 Jun; 104(6):1401-5. PubMed ID: 19491852
[TBL] [Abstract][Full Text] [Related]
28. Determination of erythrocyte polyamines as a predictive method in tumour diagnosis. An animal study with chemically induced tumours.
Quemener V; Havouis R; Khan NA; Martin C; Bouet F; Moulinoux JP
Anticancer Res; 1995; 15(6B):2517-22. PubMed ID: 8669816
[TBL] [Abstract][Full Text] [Related]
29. Fibronectin concentration in ascites differentiates between malignant and nonmalignant ascites.
Schölmerich J; Volk BA; Köttgen E; Ehlers S; Gerok W
Gastroenterology; 1984 Nov; 87(5):1160-4. PubMed ID: 6479538
[TBL] [Abstract][Full Text] [Related]
30. The laparoscopic evaluation of ascites.
Inadomi JM; Kapur S; Kinkhabwala M; Cello JP
Gastrointest Endosc Clin N Am; 2001 Jan; 11(1):79-91. PubMed ID: 11175976
[TBL] [Abstract][Full Text] [Related]
31. Total discrimination of peritoneal malignant ascites from cirrhosis- and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase.
Castaldo G; Oriani G; Cimino L; Topa M; Mostarda I; Castellano L; Del Vecchio-Blanco C; Budillon G; Salvatore F; Sacchetti L
Clin Chem; 1994 Mar; 40(3):478-83. PubMed ID: 8131285
[TBL] [Abstract][Full Text] [Related]
32. [Differentiation of malignant and non-malignant origin of ascites by determination of levels of cholesterol and lactate dehydrogenase in ascitic fluid is not absolute].
Gasko R; Klímová N
Vnitr Lek; 2000 Jan; 46(1):5-11. PubMed ID: 10953656
[TBL] [Abstract][Full Text] [Related]
33. C-reactive protein and insulin-like growth factor-1 in differential diagnosis of ascites.
Abdel-Razik A; Eldars W; Elhelaly R; Elzehery R
J Gastroenterol Hepatol; 2016 Nov; 31(11):1868-1873. PubMed ID: 27010362
[TBL] [Abstract][Full Text] [Related]
34. [Urine levels of polyamine in patients with or without cancer].
Tsunoda A
Nihon Geka Gakkai Zasshi; 1987 Jul; 88(7):816-25. PubMed ID: 3670267
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic dilemma in an elderly woman with intractable ascites and elevated CA-125 level.
Gupta S; Maheshwari A; Wuntkal R; Mazid T; Tongaonkar HB
J Assoc Physicians India; 2006 Aug; 54():655-6. PubMed ID: 16941798
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic possibilities of laparoscopy in the assessment of the stage in stomach cancer].
Popova TN; Korzhenskiĭ FP
Khirurgiia (Mosk); 1989 May; (5):33-4. PubMed ID: 2525649
[TBL] [Abstract][Full Text] [Related]
37. Fibrinolytic characteristics and their significance in malignant, tuberculous and cirrhotic pleural and ascitic fluids.
Lu XG; Mao JS; Tong JF; Zhu L; Liu J; Gong XB; Huang J
Int J Lab Hematol; 2007 Apr; 29(2):132-8. PubMed ID: 17474886
[TBL] [Abstract][Full Text] [Related]
38. Lymphocyte subsets and cytokines in ascitic fluid of decompensated cirrhotic patients with and without spontaneous ascites infection.
Kiyici M; Nak SG; Budak F; Gurel S; Oral B; Dolar E; Gulten M
J Gastroenterol Hepatol; 2006 Jun; 21(6):963-9. PubMed ID: 16724979
[TBL] [Abstract][Full Text] [Related]
39. [The analysis of ascitic fluid].
González Maldonado JJ
Rev Gastroenterol Mex; 1993; 58(2):170-2. PubMed ID: 7747028
[TBL] [Abstract][Full Text] [Related]
40. HLA-G is a potential tumor marker in malignant ascites.
Singer G; Rebmann V; Chen YC; Liu HT; Ali SZ; Reinsberg J; McMaster MT; Pfeiffer K; Chan DW; Wardelmann E; Grosse-Wilde H; Cheng CC; Kurman RJ; Shih IeM
Clin Cancer Res; 2003 Oct; 9(12):4460-4. PubMed ID: 14555519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]